 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/29/2024 |
$0.37 |
$0.38 |
$0.35 |
$0.36 |
45.40K | | 04/30/2024 |
$0.35 |
$0.37 |
$0.32 |
$0.33 |
105.50K | | 05/01/2024 |
$0.34 |
$0.34 |
$0.29 |
$0.30 |
692.30K | | 05/02/2024 |
$0.30 |
$0.31 |
$0.27 |
$0.28 |
413.60K | | 05/03/2024 |
$0.30 |
$0.31 |
$0.27 |
$0.27 |
393.80K |
|
|
| Kazia Therapeutics is an oncology-focused biotechnology company that has a portfolio of development candidates in a range of oncology indications. Co.'s primary development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase/Akt/mTor pathway, that is being developed as a potential therapy for glioblastoma as well as other forms of brain cancer. Paxalisib is orally administered and is presented in a 15mg capsule formulation. Co.'s second development candidate is EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3. EVT801 selectively targets lymphangiogenesis, the formation of new lymphatic vessels. | |
|
Kazia Therapeutics (KZIA) has the following price history information. Looking back at KZIA historical stock prices for the last five trading days, on April 29, 2024, KZIA opened at $0.37, traded as high as $0.38 and as low as $0.35, and closed at $0.36. Trading volume was a total of 45.40K shares. On April 30, 2024, KZIA opened at $0.35, traded as high as $0.37 and as low as $0.32, and closed at $0.33. Trading volume was a total of 105.50K shares. On May 01, 2024, KZIA opened at $0.34, traded as high as $0.34 and as low as $0.29, and closed at $0.30. Trading volume was a total of 692.30K shares. On May 02, 2024, KZIA opened at $0.30, traded as high as $0.31 and as low as $0.27, and closed at $0.28. Trading volume was a total of 413.60K shares. On May 03, 2024, KZIA opened at $0.30, traded as high as $0.31 and as low as $0.27, and closed at $0.27. Trading volume was a total of 393.80K shares.
KZIA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Kazia Therapeutics shares, starting with a $10,000 purchase of KZIA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/06/2014 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$15.76 |
|
| End price/share: |
$0.27 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.29% |
|
| Average Annual Total Return: |
-33.41% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$171.43 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/29/2024 | $0.36 | | 04/30/2024 | $0.33 | | 05/01/2024 | $0.30 | | 05/02/2024 | $0.28 | | 05/03/2024 | $0.27 |
|
|
